|
VPS37A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.946440E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.802300E-02 |
| Normal-vs-Stage2 |
1.096760E-01 |
| Normal-vs-Stage3 |
2.336900E-03 |
| Normal-vs-Stage4 |
4.955900E-03 |
| Stage1-vs-Stage2 |
6.417800E-01 |
| Stage1-vs-Stage3 |
4.250500E-02 |
| Stage1-vs-Stage4 |
1.375240E-01 |
| Stage2-vs-Stage3 |
3.855800E-01 |
| Stage2-vs-Stage4 |
4.802000E-01 |
| Stage3-vs-Stage4 |
9.384800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.517810E-02 |
| Normal-vs-AfricanAmerican |
1.493440E-01 |
| Normal-vs-Asian |
1.151050E-01 |
| Caucasian-vs-AfricanAmerican |
8.736400E-01 |
| Caucasian-vs-Asian |
6.527600E-01 |
| AfricanAmerican-vs-Asian |
8.780000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.296600E-03 |
| Normal-vs-Female |
3.634100E-02 |
| Male-vs-Female |
3.131200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.813800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.101700E-03 |
| Normal-vs-Age(61-80Yrs) |
8.700300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.691900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.324600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.152400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.749830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.178200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.058400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.158400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.407000E-01 |
| Classical-VS-Follicular |
3.464600E-01 |
| Classical-VS-Other |
4.256800E-01 |
| Classical-VS-Normal |
7.560000E-02 |
| Tall-VS-Follicular |
8.114400E-01 |
| Tall-VS-Other |
7.402000E-01 |
| Tall-VS-Normal |
3.080300E-02 |
| Follicular-VS-Other |
7.144800E-01 |
| Follicular-VS-Normal |
2.866100E-02 |
| Other-VS-Normal |
1.138010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.680370E-03 |
| Normal-vs-N1 |
1.412250E-02 |
| N0-vs-N1 |
9.459000E-01 |
|
|
